Abstract:Introduction Two million older Americans from underrepresented racial and ethnic minority groups (URGs) have early-stage Alzheimer's disease and related dementias (ADRD). Recent neuroimaging and clinical trials focus on individuals with early-stage ADRD, which is crucial to the development of disease modification strategies. Despite recognition of the need to increase URG engagement in these studies, enrollment remains low. A major barrier to improving URG participation rates is the lack of best practices in recruitment and referral processes. The aim of these analyses was to take a first step in examining reasons for these disparities by comparing referral sources for ADRC enrollment of URG participants with early-stage ADRD. Methods These analyses included data from 48,330 participants across 46 ADRCs, obtained through the National Alzheimer's Coordinating Center Uniform Data Set. Descriptive statistics from 5 racial/ethnic groups at baseline (visit 1) were compared using one-way analysis of variance models (ANOVAs) and chi-square tests. Generalized multinomial logistic regression models were used to examine the association of racial/ethnic group and the types of referral sources (professional, non-professional and other), with ‘non-professional’ as the reference category. The ‘professional’ category included referrals made by healthcare professionals or ADRC staff, while the ‘non-professional’ category included referrals made by family and friends. This association was examined in three samples: (1) the entire sample, (2) individuals with a baseline diagnosis of mild cognitive impairment (MCI) or dementia and a baseline global Clinical Depression Rating (CDR) of 0.5 or 1, and (3) individuals who had completed magnetic resonance imaging (MRI) at any point and a baseline diagnosis of MCI or dementia and a baseline global CDR of 0.5 or 1. Significance was set at p <0.05. Results Descriptive statistics are shown in Table 1. The sample included 35,358 (73.2%) Non-Hispanic White participants, 4,138 (8.6%) Hispanic participants, 6,766 (14%) Non-Hispanic Black participants, 1,392 (2.9%) Non-Hispanic Asian participants, and 676 (1.4%) participants of other racial and ethnic groups. Across the entire sample, Non-Hispanic Black participants were less likely to be referred by a professional contact than Non-Hispanic White participants, but more likely to be referred by family or friends (Table 2). A similar pattern was observed in participants who had a diagnosis of MCI or dementia and a global CDR of 0.5 or 1 at baseline - both overall (Table 3) and in those who had completed MRI (Table 4). These findings remained significant after adjusting for age, gender, education, and CDR score. Conclusions A lack of healthcare professional-facilitated recruitment may contribute to the disproportionately lower research participation in URGs in early-stage ADRD, including those who are willing to complete investigations such as MRI. There is a need at a national level to develop recruitment strategies to increase URG representation, particularly for Non-Hispanic Black older adults. Further studies are needed to examine how factors affecting health equity may contribute to this disparity.

Participant diversity is necessary to advance brain aging research

Guidelines for Inclusive and Diverse Human Neuroscience Research Practices

The importance of diversity in cognitive neuroscience

Harnessing population diversity: in search of tools of the trade

Diversity in the study of aging and lifespan development

The end game: respecting major sources of population diversity

A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce

A service-oriented approach to clinical trial recruitment for dementia and brain health: Methods and case examples of MyAlliance for Brain Health

Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease

Why and how to collect representative study samples in educational neuroscience research

Racial and Ethnic Disparities in Participation at Alzheimer's Disease Research Centers

Barriers and facilitators to participating in Alzheimer's disease biomarker research in black and white older adults

Traversing the Aging Research and Health Equity Divide: Toward Intersectional Frameworks of Research Justice and Participation

Enhancing diversity of clinical trial populations in multiple sclerosis

Brain health in diverse settings: How age, demographics and cognition shape brain function

Perceptions about dementia clinical trials among underrepresented populations: a nationally representative survey of U.S. dementia caregivers

Recruiting a prospective community cohort to study Alzheimer's disease and structural and social determinants of health among adults racialized as Black: The ARCHES cohort

Bridging the gap: Multi-omics profiling of brain tissue in Alzheimer's disease and older controls in multi-ethnic populations

Public and participant involvement as a pathway to inclusive dementia research

Brain clocks capture diversity and disparities in aging and dementia across geographically diverse populations

Advancing Research on Diversity and Disparities Among Aging Adults